查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2028 年结核病疫苗市场
市场调查报告书
商品编码
1215700

2022-2028 年结核病疫苗市场

Tuberculosis Vaccine Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3个工作天内

价格

在预测期内，全球结核病疫苗市场预计将以 8.4% 的复合年增长率显着增长。 几种类型的研究正在进行中，极大地支持了市场的增长。 根据世界卫生组织 2021 年世界结核病 (TB) 报告，2021 年 8 月有 25 种药物处于 I、II 或 III 期试验，用于治疗药物敏感的结核病、耐多药结核病或结核病感染。事实证明， 此外，2021 年 4 月，EDCTP 和阿姆斯特丹国际卫生髮展研究所 (AIGHD) 在结核病疫苗虚拟世界论坛上发布了全球结核病疫苗研发路线图。 它是与世界卫生组织 (WHO) 密切合作进行的。

此外，市场上的参与者也为市场的增长做出了重大贡献。 例如，2021 年 7 月，Biofabri 和 IAVI 合作对结核病 (TB) 候选疫苗 MTBVAC 进行了功效试验。 此外，免疫接种的副作用和政府批准疫苗所需的时间是阻碍市场增长的主要因素。 疫苗接种意识的提高和政府对疫苗接种计划的资助增加可能会在预测期内为市场带来新的增长机会。

结核病疫苗市场按区域划分为北美、欧洲、亚太地区和世界其他地区。 预计亚太地区将在该市场中表现出最快的增长。 印度、中国、印度尼西亚、菲律宾和巴基斯坦等国家的肺结核病例数很高。 根据世界卫生组织的数据，到 2020 年，这些国家也将占结核病死亡人数的 60%。 此外，复杂的政府医疗保健政策来对抗结核病和更好的医疗保健基础设施可能会帮助北美地区在预测期内保持其市场主导地位。

内容

第 1 章报告概述

  • 当前行业分析和增长前景
  • 研究方法和工具
  • 市场细分
    • 按细分
    • 按地区细分

第 2 章市场概述和洞察

  • 调查范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 推荐
    • 总结

第三章竞争格局

  • 主要公司分析
    • 概览
    • 财务分析
    • SWOT 分析
    • 近期趋势
  • 关键战略分析

第 4 章市场决定因素

  • 激励因素
  • 阻碍因素
  • 商机

第 5 章市场细分

  • 全球结核病疫苗市场：按类型分类
    • 免疫治疗疫苗
    • 加强疫苗
  • 全球结核病疫苗市场：按最终用户分类
    • 医院
    • 医务室
    • 其他

第六章区域分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 世界其他地方
    • 拉丁美洲
    • 中东和非洲

第七章公司简介

  • AJ Vaccines A/S
  • China National Pharmaceutical Group Corp
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • GreenSignal Bio Pharma Pvt. Ltd.
  • InterVax Ltd.
  • Japan BCG Laboratory
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Ltd.
  • Statens Serum Institut
  • Taj Pharmaceuticals Ltd.
  • Torlak Institute of Virology.
Product Code: OMR2026756

Title:Global Tuberculosis Vaccine Market Size, Share and Trends Analysis Report, By Type (Immunotherapeutic Vaccine and Booster Vaccine), By Application (Hospitals, Clinics, and Others), Forecast Period (2022-2028).

The global tuberculosis vaccine market is anticipated to grow at a substantial CAGR of 8.4% during the forecast period. Several types of research are in pipeline which is significantly supporting the market growth. According to the WHO's global tuberculosis (TB) report 2021, 25 medicines were in Phase I, Phase II, or Phase III studies in August 2021 for the treatment of drug-susceptible TB, MDR-TB, or TB infection. Besides, in April 2021, EDCTP and the Amsterdam Institute for Global Health and Development (AIGHD) launched a global TB vaccine R&D roadmap at the Virtual Global Forum on TB Vaccines. The project was conducted in close collaboration with the World Health Organization.

In addition, the players operating in the market are also helping significantly in the growth of the market. For instance, in July 2021, Biofabri and IAVI had partnered for efficacy trials of tuberculosis (TB) vaccine candidate MTBVAC. Additionally, side effects occurring from the vaccinations and the government approval time for the vaccine are the major factors that may hinder the growth of the market. Increasing awareness about vaccination and growing government funding for vaccination programs may bring new growth opportunities to the market during the forecast period.

The global tuberculosis vaccine market is segmented based on type and application. Based on type, the market is bifurcated into immunotherapeutic vaccines and booster vaccines. Based on application, the market is further sub-categorized into hospitals, clinics, and others. The immunotherapeutic vaccines such as the immune BCG segment accounted for the highest share in the past and are also the fastest-growing segment during the forecast period.

Geographically tuberculosis vaccine market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific region will show the fastest growth in this market. Countries such as India, China, Indonesia, the Philippines, and Pakistan have a high number of TB cases. And according to the World Health Organization, these countries accounted for 60% of the total TB deaths in 2020. Moreover, sophisticated healthcare government policies toward exterminating TB, and better healthcare infrastructure may support the North American region to maintain its dominance in the market during the forecast period.

The major market players in the global tuberculosis vaccine market include Pfizer Inc., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Ltd., Taj Pharmaceuticals Ltd., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global tuberculosis vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global tuberculosis Vaccine Market Research and Analysis by Type
  • Global tuberculosis Vaccine Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global tuberculosis vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global tuberculosis vaccine market.
  • Insights about market determinants that are stimulating the global tuberculosis vaccine market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Tuberculosis Vaccine Market by Type
    • 5.1.1. Immunotherapeutic Vaccine
    • 5.1.2. Booster Vaccine
  • 5.2. Global Tuberculosis Vaccine Market by End-User
    • 5.2.1. Hospitals
    • 5.2.2. Clinics
    • 5.2.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East & Africa

7. Company Profiles

  • 7.1. AJ Vaccines A/S
  • 7.2. China National Pharmaceutical Group Corp
  • 7.3. Dr. Reddy's Laboratories Ltd.
  • 7.4. GlaxoSmithKline PLC
  • 7.5. GreenSignal Bio Pharma Pvt. Ltd.
  • 7.6. InterVax Ltd.
  • 7.7. Japan BCG Laboratory
  • 7.8. Merck & Co. Inc.
  • 7.9. Novartis International AG
  • 7.10. Pfizer Inc.
  • 7.11. Sanofi SA
  • 7.12. Serum Institute of India Ltd.
  • 7.13. Statens Serum Institut
  • 7.14. Taj Pharmaceuticals Ltd.
  • 7.15. Torlak Institute of Virology.

LIST OF TABLES

  • 1. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL IMMUNOTHERAPEUTIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL BOOSTER TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 5. GLOBAL TUBERCULOSIS VACCINE IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL TUBERCULOSIS VACCINE IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL TUBERCULOSIS VACCINE IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 10. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 12. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 14. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 18. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 3. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL IMMUNOTHERAPEUTIC TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL BOOSTER TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL TUBERCULOSIS VACCINE IN HOSPITALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL TUBERCULOSIS VACCINE IN CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL TUBERCULOSIS VACCINE IN OTHER END-USERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 9. US TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 10. CANADA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 11. UK TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. FRANCE TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. GERMANY TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. ITALY TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. SPAIN TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. REST OF EUROPE TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. INDIA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. CHINA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. JAPAN TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. SOUTH KOREA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)